U.S.-based companies announced more than 153,000 job cuts in October, the research firm Challenger, Gray…
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Lu177-B7H3 monoclonal antibody is first in class targeted radiopharmaceutical in development against the…